Regulatory Considerations For Process Intensification

Source: Sartorius

What are the regulatory considerations for implementing process intensification? In this segment of the BioProcess Online Live! event “Upstream Process Intensification In Practice,” Sonnet Buotherapeutics CTO Susan Dexter and process intensification pioneer Parrish Galliher cover the fundamental aspects of the FDA’s expectations around minor and major change reporting and process validation.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online